Celsius Holdings, Inc. to Present at Upcoming June Investor Conferences

STIFEL 2023 Cross Sector Insight Conference – June 6, 2023Evercore ISI 3rd Annual Consumer and Retail Conference – June 14, 2023Jefferies Consumer Conference – June 20-21, 2023 BOCA RATON, Fla., June 5, 2023 /PRNewswire/ — Celsius Holdings, Inc., (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today announced the company will present at upcoming … Read more

Lunit und Capio S:t Göran Hospital arbeiten zusammen, um den Mangel an Radiologen mit KI-gestützter Mammographie-Analyse zu beheben

– Lunit und Schwedens größtes Privatkrankenhaus leisten Pionierarbeit bei der Kombination von Fachwissen der Radiologen mit KI SEOUL, Südkorea, 5. Juni, 2023 /PRNewswire/ — Lunit (KRX:328130.KQ), ein weltweit führender Anbieter von KI-gestützten Krebsdiagnoselösungen, gab heute die Unterzeichnung einer Liefer- und Lizenzvereinbarung mit dem Capio S:t Göran Hospital in Stockholm, Schweden, bekannt. Im Rahmen der Vereinbarung … Read more

Conformal Medical Raises $35 Million in Oversubscribed Series D Round

The round was led by SPRIG Equity with participation from all major Series C investors NASHUA, N.H., June 5, 2023 /PRNewswire/ — Conformal Medical, Inc., a medical device company developing next-generation left atrial appendage occlusion (LAAO) technology, today announced the successful completion of its Series D funding round, raising a total of $35 million. Conformal Medical’s CLAAS® Implant (PRNewsfoto/Conformal Medical, Inc.) “SPRIG Equity is focused on enabling transformative medical technology companies to achieve … Read more

Endo Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology®

DUBLIN, June 5, 2023 /PRNewswire/ — Endo International plc (OTC: ENDPQ) announced today that post-hoc data from two Phase 3 studies of XIAFLEX® (collagenase clostridium histolyticum, or CCH, injection 0.9 mg) in treating men with Peyronie’s disease (PD) were published by peer-reviewed journal Urology®. Read the article here. “The data analysis points to the importance … Read more

Carisma Therapeutics to Present at Upcoming Investor Conferences in June 2023

PHILADELPHIA, June 5, 2023 /PRNewswire/ — Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at several investor conferences in June 2023. These investor conferences include: Jefferies Global Healthcare Conference Steven Kelly, President and Chief Executive Officer, … Read more

Duke First Amendment Clinic Assists Blue Ridge Environmental Defense League with Request to the North Carolina Department of Environmental Quality in September-2022

Long-Delayed Public Records Request  DURHAM, N.C., June 5, 2023 /PRNewswire/ — After an almost nine-month wait, the North Carolina Department of Environmental Quality (DEQ) finally provided public records requested by Blue Ridge Environmental Defense League in September 2022. The records requested were regarding the agency’s efforts to communicate with the public on the health advisories … Read more

BIOLASE Takes Steps to Improve Operating Efficiency as the Company Pursues Sales and Profitability Goals

LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, is taking the necessary steps to optimize operations to capitalize on the rising business momentum for its market-leading dental lasers. The Company believes its revenue-generating strategies and prudent management of its expenses, combined with the completion of its recent … Read more

Mehr als 450 Unternehmen nutzen Veeva Vault eTMF für mehr Effizienz im Prüfwesen und der Inspektionsbereitschaft

Unternehmen modernisieren das TMF-Management, um die Automatisierung und Geschwindigkeit zu erhöhen BARCELONA, Spanien, 5. Juni 2023 /PRNewswire/ — Da die Branche den klinischen Betrieb vorantreibt, hat die Einführung von Anwendungen auf einer einheitlichen Plattform höchste Priorität, um die Effizienz von Studien und die Einhaltung von Vorschriften zu verbessern. Mehr als 450 Biopharma-Unternehmen – darunter 18 … Read more

More Than 450 Companies Adopt Veeva Vault eTMF for Improved Trial Efficiency and Inspection Readiness

Companies modernizing TMF management to drive automation and speed BARCELONA, Spain, June 5, 2023 /PRNewswire/ —  As the industry advances clinical operations, adopting applications on a unified platform is a top priority to increase study efficiency and compliance. More than 450 biopharma companies—including 18 of the top 20 pharmas and 4 of the top 6 … Read more